A Phase II Study of Pirfenidone Plus PD-1 Inhibitor With or Without Hypofractionated Radiotherapy for Refractory pMMR/MSS Colorectal Cancer
Clinical trial NCT07644286 · RECRUITING
Trial details
- NCT number
- NCT07644286
- Sponsor
- Tao Zhang
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-01
- Primary completion
- 2027-01-25
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.